These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Gandolfo P; Patte C; Leprince J; Thoumas JL; Vaudry H; Tonon MC Eur J Pharmacol; 1997 Mar; 322(2-3):275-81. PubMed ID: 9098698 [TBL] [Abstract][Full Text] [Related]
4. GABA inhibits endozepine release from cultured rat astrocytes. Patte C; Gandolfo P; Leprince J; Thoumas JL; Fontaine M; Vaudry H; Tonon MC Glia; 1999 Feb; 25(4):404-11. PubMed ID: 10028922 [TBL] [Abstract][Full Text] [Related]
6. The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes. Lamacz M; Tonon MC; Smih-Rouet F; Patte C; Gasque P; Fontaine M; Vaudry H Brain Res Mol Brain Res; 1996 Apr; 37(1-2):290-6. PubMed ID: 8738163 [TBL] [Abstract][Full Text] [Related]
7. The triakontatetraneuropeptide TTN increases [CA2+]i in rat astrocytes through activation of peripheral-type benzodiazepine receptors. Gandolfo P; Louiset E; Patte C; Leprince J; Masmoudi O; Malagon M; Gracia-Navarro F; Vaudry H; Tonon MC Glia; 2001 Aug; 35(2):90-100. PubMed ID: 11460265 [TBL] [Abstract][Full Text] [Related]
8. Detection, characterization and biological activities of [bisphospho-thr3,9]ODN, an endogenous molecular form of ODN released by astrocytes. Gach K; Belkacemi O; Lefranc B; Perlikowski P; Masson J; Walet-Balieu ML; Do-Rego JC; Galas L; Schapman D; Lamtahri R; Tonon MC; Vaudry D; Chuquet J; Leprince J Neuroscience; 2015 Apr; 290():472-84. PubMed ID: 25639232 [TBL] [Abstract][Full Text] [Related]
9. Regulation of proopiomelanocortin gene expression by endogenous ligands of the GABAA receptor complex as evaluated by in situ hybridization in the rat pars intermedia. Garcia de Yebenes E; Li S; Pelletier G Brain Res; 1997 Mar; 750(1-2):277-84. PubMed ID: 9098553 [TBL] [Abstract][Full Text] [Related]
10. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes. Berkovich A; McPhie P; Campagnone M; Guidotti A; Hensley P Mol Pharmacol; 1990 Feb; 37(2):164-72. PubMed ID: 2154668 [TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. Masmoudi O; Gandolfo P; Leprince J; Vaudry D; Fournier A; Patte-Mensah C; Vaudry H; Tonon MC FASEB J; 2003 Jan; 17(1):17-27. PubMed ID: 12522108 [TBL] [Abstract][Full Text] [Related]
12. Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish. Matsuda K; Wada K; Miura T; Maruyama K; Shimakura SI; Uchiyama M; Leprince J; Tonon MC; Vaudry H Neuroscience; 2007 Dec; 150(2):425-32. PubMed ID: 17936516 [TBL] [Abstract][Full Text] [Related]
13. The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes. Patte C; Vaudry H; Desrues L; Gandolfo P; Strijdveen I; Lamacz M; Tonon MC FEBS Lett; 1995 Apr; 362(2):106-10. PubMed ID: 7720854 [TBL] [Abstract][Full Text] [Related]
14. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Ferrero P; Santi MR; Conti-Tronconi B; Costa E; Guidotti A Proc Natl Acad Sci U S A; 1986 Feb; 83(3):827-31. PubMed ID: 3456171 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. do Rego JC; Orta MH; Leprince J; Tonon MC; Vaudry H; Costentin J Neuropsychopharmacology; 2007 Jul; 32(7):1641-8. PubMed ID: 17151595 [TBL] [Abstract][Full Text] [Related]
16. The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism. Hamdi Y; Kaddour H; Vaudry D; Bahdoudi S; Douiri S; Leprince J; Castel H; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O PLoS One; 2012; 7(8):e42498. PubMed ID: 22927932 [TBL] [Abstract][Full Text] [Related]
17. Further studies on the mechanism of action of the endogenous benzodiazepine receptor ligand octadecaneuropeptide on gonadotropin-releasing hormone gene expression in the rat brain. Li S; Pelletier G Neuroendocrinology; 1996 Aug; 64(2):79-84. PubMed ID: 8857601 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of the potential endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), on gonadotropin-releasing hormone gene expression in the male rat brain. Li S; Pelletier G Neuroreport; 1995 Jun; 6(9):1354-56. PubMed ID: 7670003 [TBL] [Abstract][Full Text] [Related]
19. Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. Masmoudi O; Gandolfo P; Tokay T; Leprince J; Ravni A; Vaudry H; Tonon MC J Neurochem; 2005 Aug; 94(3):561-71. PubMed ID: 16033415 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotection with the Endozepine Octadecaneuropeptide, ODN. Masmoudi-Kouki O; Hamdi Y; Ghouili I; Bahdoudi S; Kaddour H; Leprince J; Castel H; Vaudry H; Amri M; Vaudry D; Tonon MC Curr Pharm Des; 2018; 24(33):3918-3925. PubMed ID: 30417780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]